CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis

Myelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface g...

Full description

Bibliographic Details
Main Authors: A. Nonino, J.M. Nascimento, C.C. Mascarenhas, J.F. Mazzeu, R.W. Pereira, R.H. Jacomo
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2018-12-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000100610&lng=en&tlng=en
_version_ 1811265313581301760
author A. Nonino
J.M. Nascimento
C.C. Mascarenhas
J.F. Mazzeu
R.W. Pereira
R.H. Jacomo
author_facet A. Nonino
J.M. Nascimento
C.C. Mascarenhas
J.F. Mazzeu
R.W. Pereira
R.H. Jacomo
author_sort A. Nonino
collection DOAJ
description Myelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface glycoprotein with many functions, such as acting as a phagocytosis inhibitor of the expressing cell, that is increased in normal hematopoietic stem and progenitor cells mobilized into the blood and several human cancer-initiating cells, such as in acute myeloid leukemia. We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. Exposure of control HPCs to the cytokines transforming growth factor β and stromal-derived factor 1, which are important regulators of hematopoietic stem cell cycling and are overexpressed in patients with MF, did not modulate CD47 expression.
first_indexed 2024-04-12T20:20:38Z
format Article
id doaj.art-65d50cb34fc6471ba657dc138d704658
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-04-12T20:20:38Z
publishDate 2018-12-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-65d50cb34fc6471ba657dc138d7046582022-12-22T03:18:00ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2018-12-0152110.1590/1414-431x20187784S0100-879X2019000100610CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosisA. NoninoJ.M. NascimentoC.C. MascarenhasJ.F. MazzeuR.W. PereiraR.H. JacomoMyelofibrosis (MF) is characterized by increased circulating hematopoietic progenitor cells (HPCs), abnormal cytokine levels, and the survival advantage of neoplastic progenitors over their normal counterparts, which leads to progressive disappearance of polyclonal hematopoiesis. CD47 is a surface glycoprotein with many functions, such as acting as a phagocytosis inhibitor of the expressing cell, that is increased in normal hematopoietic stem and progenitor cells mobilized into the blood and several human cancer-initiating cells, such as in acute myeloid leukemia. We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. Exposure of control HPCs to the cytokines transforming growth factor β and stromal-derived factor 1, which are important regulators of hematopoietic stem cell cycling and are overexpressed in patients with MF, did not modulate CD47 expression.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000100610&lng=en&tlng=enMyeloproliferative disordersPrimary myelofibrosisHematopoietic stem cellsNeoplastic stem cellsAntigensCD47
spellingShingle A. Nonino
J.M. Nascimento
C.C. Mascarenhas
J.F. Mazzeu
R.W. Pereira
R.H. Jacomo
CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
Brazilian Journal of Medical and Biological Research
Myeloproliferative disorders
Primary myelofibrosis
Hematopoietic stem cells
Neoplastic stem cells
Antigens
CD47
title CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
title_full CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
title_fullStr CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
title_full_unstemmed CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
title_short CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
title_sort cd47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis
topic Myeloproliferative disorders
Primary myelofibrosis
Hematopoietic stem cells
Neoplastic stem cells
Antigens
CD47
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2019000100610&lng=en&tlng=en
work_keys_str_mv AT anonino cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis
AT jmnascimento cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis
AT ccmascarenhas cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis
AT jfmazzeu cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis
AT rwpereira cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis
AT rhjacomo cd47expressionisdecreasedinhematopoieticprogenitorcellsinpatientswithmyelofibrosis